Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29682050 | 1.00 | ALOX5 (0.55) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL30543005 | 0.82 | MEN1 (0.52) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL2725777 | 0.82 | MEN1 (0.52) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL15366767 | 0.82 | MEN1 (0.52) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL29591632 | 0.81 | ALOX5 (0.59) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL2709851 | 0.81 | ALOX5 (0.59) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL31369138 | 0.81 | GPR84 (0.42) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL300507 | 0.81 | ALOX5 (0.57) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL29362847 | 0.81 | ALOX5 (0.57) | ALOX5GPR84MEN1KMT2AKDM4E | |
| SCHEMBL2084490 | 0.80 | ALOX5 (0.58) | ALOX5GPR84MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020209307-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | 出光興産株式会社 | 2020-10-15 | — | — | WO | disclosed |
| WO-2020209309-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE COMPRISING SAME | 出光興産株式会社 | 2020-10-15 | — | — | WO | disclosed |
| WO-2020209310-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE COMPRISING SAME | 出光興産株式会社 | 2020-10-15 | — | — | WO | disclosed |
| US-20110049482-A1 | Novel aromatic compound and organic electroluminescent element containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-03-03 | — | — | US | disclosed |
| US-7790892-B2 | Aromatic compound and organic electroluminescent element containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-09-07 | — | — | US | disclosed |
| US-20050214565-A1 | Novel aromatic compound and organic electroluminescent element containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2005-09-29 | — | — | US | disclosed |
| EP-1496041-A1 | NOVEL AROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCNET ELEMENT CONTAINING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110049482-A1 | Novel aromatic compound and organic electroluminescent element containing the same | TYR, EML4, TCF7L2 | ALOX5 3307/4885GPR84 3527/4885MEN1 2095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.